Ion AmpliSeq™ Ready-to-Use Panels
Ion AmpliSeq™ Cancer Hotspot Panel v2
This focused cancer panel is now expanded to target "hot spot" regions of 50 oncogenes and tumor suppressor genes, with wide coverage of KRAS, BRAF, and EGFR genes
Ion AmpliSeq™ Comprehensive Cancer Panel
Broad oncology panel targeting exons within >400 oncogenes and tumor suppressor genes
Ion AmpliSeq™ Inherited Disease Panel
Broad inherited disease panel targeting exons of over 300 genes associated with over 700 inherited diseases including neuromuscular, cardiovascular, developmental, and metabolic diseases
Ion AmpliSeq™ Sample ID Panel
Human SNP genotyping panel that allows generation of unique identification code for research samples in sequencing runs providing increased confidence during data analysis
Transformative Target Selection Technology
Ion AmpliSeq™ Ready-to-use Panels transform genetic research with ultrahigh-multiplex PCR primer pools designed for fast and simple production of thousands of targeted amplicons. The breakthrough low-input DNA requirement of the Ion AmpliSeq™ Panels enables the practical interrogation of research samples containing as little as 10 ng of input DNA, such as formalin-fixed, paraffin-embedded (FFPE) and fine needle biopsy (FNB) samples.
The convenient pre-designed panels allow researchers to focus on data generation and analysis, not on the labor-intensive primer design and target selection steps. While hybridization-based target selection methods require 7 to 72 hours to complete both target selection and library preparation, Ion AmpliSeq™ technology makes it possible to complete the entire process in just 3.5 hours using simple PCR reactions. Additionally, Ion AmpliSeq™ library construction steps are automated using standard 96-well plate-based protocols—further simplifying the workflow and allowing large projects to be rapidly completed without additional sample transfer steps.
For research use only. Not intended for any animal or human therapeutic or diagnostic use.